Improved Immunogenicity Against a Her2/neu-Derived Peptide by Employment of a Pan HLA DR-Binding Epitope and CpG in a BALB/c Mice Model

Publisher： Bentham Science Publishers

E-ISSN： 1875-5992|17|6|851-858

ISSN： 1871-5206

Source： Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol.17, Iss.6, 2017-06, pp. : 851-858

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Ii-Key/HER-2/neu MHC class-II antigenic epitope vaccine peptide for breast cancer

By Gillogly Michael   Kallinteris Nikoletta   Xu Minzhen   Gulfo Joseph   Humphreys Robert   Murray James  

Cancer Immunology, Immunotherapy, Vol. 53, Iss. 6, 2004-06 ,pp. : 490-496

Springer Publishing Company

Access to resources Recommend Favorite

Immunogenicity of the carcinoembryonic antigen derived peptide 694 in HLA-A2 healthy donors and colorectal carcinoma patients

By Alves Pedro   Viatte Sebastien   Fagerberg Theres   Michielin Olivier   Bricard Gabriel   Bouzourene Hanifa   Vuilleumier Henri   Kruger Thorsten   Givel Jean-Claude   Lévy Frédéric   Speiser Daniel   Cerottini Jean-Charles   Romero Pedro  

Cancer Immunology, Immunotherapy, Vol. 56, Iss. 11, 2007-11 ,pp. : 1795-1805

Springer Publishing Company

Access to resources Recommend Favorite

Her-2/neu altered peptide ligand–induced CTL responses: implications for peptides with increased HLA affinity and T-cell-receptor interaction

By Dionne Sara   Myers Cheryl   Smith Margaret   Lake Douglas  

Cancer Immunology, Immunotherapy, Vol. 53, Iss. 4, 2004-04 ,pp. : 307-314

Springer Publishing Company

Access to resources Recommend Favorite

A comparative study on the activities of six combination regimens against multidrug-resistant Mycobacterium tuberculosis infection in BALB/c mice

By Zheng Meiqin   Jin Haixia   Fu Lei   Xu Jian   Wang Bin   Zhao Weijie   Zhu Hui   Li Peng   Lu Yu   Li Qi  

Journal of Chemotherapy, Vol. 25, Iss. 2, 2013-04 ,pp. : 81-86

Maney Publishing

Access to resources Recommend Favorite

Identification of an antigenic peptide derived from the cancer-testis antigen NY-ESO-1 binding to a broad range of HLA-DR subtypes

By Neumann Frank   Wagner Claudia   Kubuschok Boris   Stevanovic Stefan   Rammensee Hans-Georg   Pfreundschuh Michael  

Cancer Immunology, Immunotherapy, Vol. 53, Iss. 7, 2004-07 ,pp. : 589-599

Springer Publishing Company

Access to resources Recommend Favorite